371 related articles for article (PubMed ID: 23948108)
1. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
[TBL] [Abstract][Full Text] [Related]
2. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
4. Impact of atrial fibrillation on 1-year outcome in patients with implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator: results from the German DEVICE Registry.
Feickert S; Ewertsen NC; Köbe J; Kleemann T; Jehle J; Senges J; Hochadel M; Andresen D; Stellbrink C; Eckardt L; Spitzer S; Brachmann J; Ince H; D'Ancona G
J Thorac Dis; 2024 Mar; 16(3):1825-1835. PubMed ID: 38617758
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
[TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
[TBL] [Abstract][Full Text] [Related]
7. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
8. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
[TBL] [Abstract][Full Text] [Related]
9. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.
Ousdigian KT; Borek PP; Koehler JL; Heywood JT; Ziegler PD; Wilkoff BL
Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):370-6. PubMed ID: 24838004
[TBL] [Abstract][Full Text] [Related]
10. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
[TBL] [Abstract][Full Text] [Related]
11. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
12. Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age - Insights from the German Device Registry.
Köbe J; Andresen D; Maier S; Stellbrink C; Kleemann T; Gonska BD; Reif S; Hochadel M; Senges J; Eckardt L
Int J Cardiol; 2017 Feb; 228():784-789. PubMed ID: 27898337
[TBL] [Abstract][Full Text] [Related]
13. Predictors of sinus rhythm return during defibrillation testing in patients with permanent atrial fibrillation undergoing implantation of a cardioverter-defibrillator.
Lelakowski J; Tomala I; Cmiel A; Rydlewska A; Majewski J; Małecka B
Kardiol Pol; 2011; 69(1):17-22. PubMed ID: 21267958
[TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
[TBL] [Abstract][Full Text] [Related]
15. Selection and outcome of implantable cardioverter-defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials.
Köbe J; Willy K; Senges J; Hochadel M; Kleemann T; Spitzer SG; Andresen D; Jehle J; Steinbeck G; Szendey I; Butter C; Brachmann J; Hoffmann E; Eckardt L
J Cardiovasc Electrophysiol; 2022 Mar; 33(3):483-492. PubMed ID: 35028995
[TBL] [Abstract][Full Text] [Related]
16. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
17. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
[TBL] [Abstract][Full Text] [Related]
19. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
[TBL] [Abstract][Full Text] [Related]
20. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
